Abstract:Chronic use of β 2-adrenoceptor agonists as a monotherapy in asthma is associated with a loss of disease control and an increased risk of mortality. Herein, we tested the hypothesis that β 2-adrenoceptor agonists, including formoterol, promote biased, β-arrestin (Arr) 2-dependent activation of the mitogen-activated protein kinases, ERK1/2, in human airway epithelial cells and, thereby, effect changes in gene expression that could contribute to their adverse clinical outcomes. Three airway epithelial cell models were used: the BEAS-2B cell line, human primary bronchial epithelial cells (HBEC) grown in submersion culture, and HBEC that were highly differentiated at an air-liquid interface. Unexpectedly, treatment of all epithelial cell models with formoterol decreased basal ERK1/2 phosphorylation. This was mediated by cAMP-dependent protein kinase and involved the inactivation of C-rapidly-activated fibrosarcoma, which attenuated downstream ERK1/2 activity, and the induction of dual-specificity phosphatase 1. Formoterol also inhibited the basal expression of early growth response-1, an ERK1/2-regulated gene that controls cell growth and repair in the airways. Neither carvedilol, a β 2-adrenoceptor agonist biased toward βArr2, nor formoterol promoted ERK1/2 phosphorylation in BEAS-2B cells, although β 2-adrenoceptor desensitization was compromised in ARRB2-deficient cells. Collectively, these results contest the hypothesis that formoterol activates ERK1/2 in airway epithelia by nucleating a βArr2 signaling complex; instead, they indicate that β 2-adrenoceptor agonists inhibit constitutive ERK1/2 activity in a cAMP-dependent manner. These findings are the antithesis of results obtained using acutely challenged native and engineered HEK293 cells, which have been used extensively to study mechanisms of ERK1/2 activation, and highlight the cell type dependence of β 2-adrenoceptor-mediated signaling. SIGNIFICANCE STATEMENT: It has been proposed that the adverse effects of β 2-adrenoceptor agonist monotherapy in asthma are mediated by genomic mechanisms that occur principally in airway epithelial cells and are the result of β-arrestin 2-dependent activation of ERK1/2. This study shows that β 2-adrenoceptor agonists, paradoxically, reduced ERK1/2 phosphorylation in airway epithelia by disrupting upstream rat sarcoma-C-rapidly accelerated fibrosarcoma complex formation and inducing dual-specificity phosphatase 1. Moreover, these effects were cAMP-dependent protein kinase-dependent, suggesting that β 2-adrenoceptor agonists were not biased toward β-arrestin 2 and acted via canonical, cAMP-dependent signaling.

The Β1-Adrenergic Receptor Mediates Extracellular Signal-Regulated Kinase Activation Via Gαs

Alpha(1a)-Adrenergic Receptor Induces Activation Of Extracellular Signal-Regulated Kinase 1/2 Through Endocytic Pathway

Agonist-induced activation of human FFA1 receptor signals to extracellular signal-regulated kinase 1 and 2 through Gq- and Gi-coupled signaling cascades

Genetic Evidence That Β-Arrestins Are Dispensable for the Initiation of Β2-Adrenergic Receptor Signaling to ERK

β2-Adrenergic Receptor-induced p38 MAPK Activation Is Mediated by Protein Kinase A Rather than by Gi or Gβγ in Adult Mouse Cardiomyocytes

Regulation of Mitogen-Activated Protein Kinases Signaling by Β-Adreno-receptor

β2-Adrenergic receptor-induced transactivation of epidermal growth factor receptor and platelet-derived growth factor receptor via Src kinase promotes rat cardiomyocyte survival.

α1 Adrenoceptor subtypes activates Ca2+ movement through stimulating a tyrosine protein kinase pathway in HEK293 cells

CAPA Periviscerokinin-Mediated Activation of MAPK/ERK Signaling Through Gq-PLC-PKC-dependent Cascade and Reciprocal ERK Activation-Dependent Internalized Kinetics of Bom-CAPA-PVK Receptor 2

β 2-Adrenoceptor Agonists Promote Extracellular Signal-Regulated Kinase 1/2 Dephosphorylation in Human Airway Epithelial Cells by Canonical, cAMP-Driven Signaling Independently of β-Arrestin 2

Gene Expression Profiles in Response to the Activation of Adrenoceptors in A7r5 Aortic Smooth Muscle Cells

Β1-Adrenergic Regulation of Rapid Component of Delayed Rectifier K+ Currents in Guinea-Pig Cardiac Myocytes.

A Novel Protein Kinase A-independent, Β-Arrestin-1-dependent Signaling Pathway for P38 Mitogen-activated Protein Kinase Activation by Β2-Adrenergic Receptors

Stimulation Of Alpha(1a) Adrenergic Receptors Induces Cellular Proliferation Or Antiproliferative Hypertrophy Dependent Solely On Agonist Concentration

Ca 2+ participates in α 1B -adrenoceptor-mediated cAMP response in HEK293 cells

Ca2+ Participates In Alpha(1b)-Adrenoceptor-Mediated Camp Response In Hek293 Cells

A2B adenosine receptor activation and modulation by protein kinase C

Multiple signalling pathways involved in beta2-adrenoceptor-mediated glucose uptake in rat skeletal muscle cells

Bombyx Adipokinetic Hormone Receptor Activates Extracellular Signal-Regulated Kinase 1 and 2 Via G Protein-Dependent PKA and PKC but Β-Arrestin-independent Pathways

Involvement of ERK1/2 Pathway in Endothelin ET_(A) and ET_(B) Receptor-Mediated Contraction in Isolated Rat Mesenteric Artery

Β 2 -Adrenergic Stimulation Compartmentalizes Β 1 Signaling into Nanoscale Local Domains by Targeting the C-Terminus of Β 1 -Adrenoceptors